Balance Sheet
Accounts PayablesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityConstruction in ProgressCurrent AssetsCurrent TaxesGoodwillGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityLong-Term Deferred TaxLong-Term InvestmentsMinority InterestNon-Current AssetsNon-Current DebtNon-Current Deferred Tax LiabilityNotes PayablesOperating LeasesOther Accumulated ExpensesOther Non-Current AssetsOther Non-Current LiabilitiesPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesReceivables - NetReceivables - OtherRetained EarningsShareholder's EquityShort term DebtShort-term InvestmentsTotal Current LiabilitiesTotal DebtTotal LiabilitiesTotal Non-Current LiabilitiesTreasury SharesWork In Process
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Dr Reddys Laboratories (RDY) Treasury Shares (2018 - 2025)

Historic Treasury Shares for Dr Reddys Laboratories (RDY) over the last 8 years, with Q3 2025 value amounting to -$22.2 million.

  • Dr Reddys Laboratories' Treasury Shares fell 10322.83% to -$22.2 million in Q3 2025 from the same period last year, while for Sep 2025 it was -$22.2 million, marking a year-over-year decrease of 10322.83%. This contributed to the annual value of $27.0 million for FY2025, which is 12500.0% up from last year.
  • As of Q3 2025, Dr Reddys Laboratories' Treasury Shares stood at -$22.2 million, which was down 10322.83% from -$26.1 million recorded in Q1 2025.
  • In the past 5 years, Dr Reddys Laboratories' Treasury Shares registered a high of $27.0 million during Q1 2021, and its lowest value of -$26.1 million during Q1 2025.
  • Moreover, its 5-year median value for Treasury Shares was -$11.6 million (2023), whereas its average is -$3.8 million.
  • Per our database at Business Quant, Dr Reddys Laboratories' Treasury Shares skyrocketed by 9426.96% in 2021 and then crashed by 31909.3% in 2025.
  • Dr Reddys Laboratories' Treasury Shares (Quarter) stood at -$22.4 million in 2021, then rose by 14.17% to -$19.2 million in 2022, then surged by 35.77% to -$12.4 million in 2023, then rose by 11.55% to -$10.9 million in 2024, then crashed by 103.23% to -$22.2 million in 2025.
  • Its Treasury Shares was -$22.2 million in Q3 2025, compared to -$26.1 million in Q1 2025 and -$10.9 million in Q3 2024.